Historically, healthcare organizations have followed the lead of published research on the efficacy of pharmacokinetic (PK) models to support point-of-care precision dosing. When a respected journal publishes a robust, peer-validated PK model analysis, clinicians often heed the results and accept that model as their organization’s default for the drug in question. However, new research shows…

The concept of precision drug-dosing has gained ground in recent years, given its ability to boost efficacy and curb side effects. Yet imprecise dosing regimens continue to be common for many drugs, leading to significant rates of adverse drug reactions (ADRs).  “ADRs are one of the top ten causes of death in the developed world,”…